ID

36345

Descripción

A Study of Different Titration Schedules of ALKS 5461 in Adults With Major Depressive Disorder (MDD); ODM derived from: https://clinicaltrials.gov/show/NCT02085135

Link

https://clinicaltrials.gov/show/NCT02085135

Palabras clave

Versiones (1)
  1. 5/5/19 5/5/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

5 de mayo de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Major Depressive Disorder NCT02085135

Inglés

Eligibility Major Depressive Disorder NCT02085135

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
body mass index of 18-40 kg/m2
Descripción

Body mass index

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1305855
have a diagnosis of mdd
Descripción

Major Depressive Disorder

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1269683
have a current major depressive episode (mde) lasting 8 weeks to 24 months
Descripción

Major depressive episode Duration

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0024517
UMLS CUI [1,2]
C0449238
have been treated with an adequate dose of an approved antidepressant during the current mde for at least 8 weeks
Descripción

Antidepressant therapy Dose Adequate

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1096649
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205411
have an inadequate response to current antidepressant treatment
Descripción

Antidepressant therapy | Response Inadequate

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1096649
UMLS CUI [2,1]
C1704632
UMLS CUI [2,2]
C0205412
agree to use an approved method of birth control for the duration of the study
Descripción

Contraceptive methods Willing

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0700589
UMLS CUI [1,2]
C0600109
additional criteria may apply
Descripción

Inclusion criteria Additional

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C1524062
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
currently pregnant or breastfeeding
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
history of or current infection with hepatitis b virus, hepatitis c virus or human immunodeficiency virus (hiv)
Descripción

Hepatitis B | Hepatitis C | HIV Infection

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019163
UMLS CUI [2]
C0019196
UMLS CUI [3]
C0019693
have experienced hallucinations, delusions, or any psychotic symptoms in the current mde
Descripción

Hallucinations During Major depressive episode | Delusions During Major depressive episode | Psychotic symptom During Major depressive episode

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0018524
UMLS CUI [1,2]
C0347984
UMLS CUI [1,3]
C0024517
UMLS CUI [2,1]
C0011253
UMLS CUI [2,2]
C0347984
UMLS CUI [2,3]
C0024517
UMLS CUI [3,1]
C0871189
UMLS CUI [3,2]
C0347984
UMLS CUI [3,3]
C0024517
have used opioid agonists (eg, codeine, oxycodone, tramadol, or morphine) or opioid antagonists (eg, naloxone, naltrexone) within 14 days
Descripción

Opioid Agonists | Codeine | Oxycodone | Tramadol | Morphine | Opioid Antagonists | Naloxone | Naltrexone

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1373059
UMLS CUI [2]
C0009214
UMLS CUI [3]
C0030049
UMLS CUI [4]
C0040610
UMLS CUI [5]
C0026549
UMLS CUI [6]
C2756979
UMLS CUI [7]
C0027358
UMLS CUI [8]
C0027360
have received electroconvulsive therapy treatment within the last 5 years
Descripción

Electroconvulsive Therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0013806
have attempted suicide within the past 2 years
Descripción

Suicide attempt

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0038663
have a history of intolerance, allergy, or hypersensitivity to buprenorphine or opioid antagonists (eg, naltrexone, naloxone)
Descripción

Intolerance to Buprenorphine | Buprenorphine allergy | Intolerance to Opioid Antagonists | Opioid antagonist allergy | Intolerance to Naltrexone | Naltrexone allergy | Intolerance to Naloxone | Naloxone allergy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1744706
UMLS CUI [1,2]
C0006405
UMLS CUI [2]
C0570524
UMLS CUI [3,1]
C1744706
UMLS CUI [3,2]
C2756979
UMLS CUI [4]
C0571190
UMLS CUI [5,1]
C1744706
UMLS CUI [5,2]
C0027360
UMLS CUI [6]
C0571191
UMLS CUI [7,1]
C1744706
UMLS CUI [7,2]
C0027358
UMLS CUI [8]
C0571192
have had a significant blood loss or blood donation with 60 days of screening
Descripción

Blood Loss Significant | Blood Donation

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3163616
UMLS CUI [1,2]
C0750502
UMLS CUI [2]
C0005794
additional criteria may apply
Descripción

Exclusion Criteria Additional

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C1524062
Volver a la parte superior de la página

Similar models

Eligibility Major Depressive Disorder NCT02085135

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Body mass index
Item
body mass index of 18-40 kg/m2
boolean
C1305855 (UMLS CUI [1])
Major Depressive Disorder
Item
have a diagnosis of mdd
boolean
C1269683 (UMLS CUI [1])
Major depressive episode Duration
Item
have a current major depressive episode (mde) lasting 8 weeks to 24 months
boolean
C0024517 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
Antidepressant therapy Dose Adequate
Item
have been treated with an adequate dose of an approved antidepressant during the current mde for at least 8 weeks
boolean
C1096649 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205411 (UMLS CUI [1,3])
Antidepressant therapy | Response Inadequate
Item
have an inadequate response to current antidepressant treatment
boolean
C1096649 (UMLS CUI [1])
C1704632 (UMLS CUI [2,1])
C0205412 (UMLS CUI [2,2])
Contraceptive methods Willing
Item
agree to use an approved method of birth control for the duration of the study
boolean
C0700589 (UMLS CUI [1,1])
C0600109 (UMLS CUI [1,2])
Inclusion criteria Additional
Item
additional criteria may apply
boolean
C1512693 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast Feeding
Item
currently pregnant or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Hepatitis B | Hepatitis C | HIV Infection
Item
history of or current infection with hepatitis b virus, hepatitis c virus or human immunodeficiency virus (hiv)
boolean
C0019163 (UMLS CUI [1])
C0019196 (UMLS CUI [2])
C0019693 (UMLS CUI [3])
Hallucinations During Major depressive episode | Delusions During Major depressive episode | Psychotic symptom During Major depressive episode
Item
have experienced hallucinations, delusions, or any psychotic symptoms in the current mde
boolean
C0018524 (UMLS CUI [1,1])
C0347984 (UMLS CUI [1,2])
C0024517 (UMLS CUI [1,3])
C0011253 (UMLS CUI [2,1])
C0347984 (UMLS CUI [2,2])
C0024517 (UMLS CUI [2,3])
C0871189 (UMLS CUI [3,1])
C0347984 (UMLS CUI [3,2])
C0024517 (UMLS CUI [3,3])
Opioid Agonists | Codeine | Oxycodone | Tramadol | Morphine | Opioid Antagonists | Naloxone | Naltrexone
Item
have used opioid agonists (eg, codeine, oxycodone, tramadol, or morphine) or opioid antagonists (eg, naloxone, naltrexone) within 14 days
boolean
C1373059 (UMLS CUI [1])
C0009214 (UMLS CUI [2])
C0030049 (UMLS CUI [3])
C0040610 (UMLS CUI [4])
C0026549 (UMLS CUI [5])
C2756979 (UMLS CUI [6])
C0027358 (UMLS CUI [7])
C0027360 (UMLS CUI [8])
Electroconvulsive Therapy
Item
have received electroconvulsive therapy treatment within the last 5 years
boolean
C0013806 (UMLS CUI [1])
Suicide attempt
Item
have attempted suicide within the past 2 years
boolean
C0038663 (UMLS CUI [1])
Intolerance to Buprenorphine | Buprenorphine allergy | Intolerance to Opioid Antagonists | Opioid antagonist allergy | Intolerance to Naltrexone | Naltrexone allergy | Intolerance to Naloxone | Naloxone allergy
Item
have a history of intolerance, allergy, or hypersensitivity to buprenorphine or opioid antagonists (eg, naltrexone, naloxone)
boolean
C1744706 (UMLS CUI [1,1])
C0006405 (UMLS CUI [1,2])
C0570524 (UMLS CUI [2])
C1744706 (UMLS CUI [3,1])
C2756979 (UMLS CUI [3,2])
C0571190 (UMLS CUI [4])
C1744706 (UMLS CUI [5,1])
C0027360 (UMLS CUI [5,2])
C0571191 (UMLS CUI [6])
C1744706 (UMLS CUI [7,1])
C0027358 (UMLS CUI [7,2])
C0571192 (UMLS CUI [8])
Blood Loss Significant | Blood Donation
Item
have had a significant blood loss or blood donation with 60 days of screening
boolean
C3163616 (UMLS CUI [1,1])
C0750502 (UMLS CUI [1,2])
C0005794 (UMLS CUI [2])
Exclusion Criteria Additional
Item
additional criteria may apply
boolean
C0680251 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial